Back to
UBS Group AG
PLXPQ18 quarters
Position history for
UBS Group AG's holdings in PLX PHARMA INC
No. Ubs exited its PLXPQ (PLX Pharma) position in Q2 2023. Its Q1 2023 13F listed 51,213 shares worth $6,657. Ubs already held PLXPQ in its Q1 2019 13F, the earliest on record, and held it in 17 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$16,000
Total Shares Change
-2,917
Quarter-by-Quarter History
Other major holders of PLXPQ: MSD Partners, L.P.